Grown Rogue International (GRUSF) Profit After Tax (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Profit After Tax of -$2.7 million for Q1 2026, down 463.75% year-over-year from $742870.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$5335.5 billion in Q4 2025.
Grown Rogue International (GRUSF) Profit After Tax (2009 - 2026) Analysis & Trends
Grown Rogue International's Profit After Tax history runs 18 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 463.75% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$2500.4 billion (down 121.3% YoY), while the FY2025 annual figure was -$622811.0, up 96.1% from the prior year.
- Profit After Tax for Q1 2026 stood at -$2.7 million, up from -$5335.5 billion in the prior quarter.
- The five-year high for Profit After Tax was $12406.7 billion in Q4 2024, with the low at -$5335.5 billion in Q4 2025.
- The 5-year median for Profit After Tax is $411979.0 (2023), against an average of $615.9 billion.
- The sharpest annual moves came in 2024 and 2026: Profit After Tax jumped 1845069479.4% in 2024, then sank 463.75% in 2026.
- Grown Rogue International's Profit After Tax stood at $155441.0 in 2022, then surged by 332.59% to $672427.0 in 2023, then surged by 1845069479.4% to $12406.7 billion in 2024, then sank by 143.01% to -$5335.5 billion in 2025, then jumped by 100.0% to -$2.7 million in 2026.
- Business Quant data shows GRUSF's Profit After Tax at -$2.7 million in Q1 2026, -$5335.5 billion in Q4 2025, and $2835.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Grown Rogue International | 123.27 Mn | 111.73 Mn | 5.37 Mn | -1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.69 Mn |
| Mar 31, 2026 | -2.70 Mn |
| Dec 31, 2025 | -5,335.55 Bn |
| Sep 30, 2025 | 2,835.15 Bn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 742,870.00 |
| Dec 31, 2024 | 12,406.75 Bn |
| Sep 30, 2024 | -667.24 Bn |
| Jun 30, 2024 | -5.54 Mn |
| Mar 31, 2024 | -4.17 Mn |
| Dec 31, 2023 | 672,427.00 |
| Oct 31, 2023 | -1.25 Mn |
| Jul 31, 2023 | 757,467.00 |
| Apr 30, 2023 | 411,979.00 |
| Jan 31, 2023 | 592,537.00 |
| Jan 31, 2022 | 155,441.00 |
| Oct 31, 2021 | 1.10 Mn |
| Jul 31, 2021 | 240,294.00 |
| Apr 30, 2021 | -1.44 Mn |
| Jan 31, 2021 | -995,789.00 |